| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Medivir AB (publ) (ST: MVIR-B)
MVIR-B Technical Analysis
5
| As on 17th Jul 2023 MVIR-B STOCK Price closed @ 7.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 8.12 & Strong Sell for SHORT-TERM with Stoploss of 8.16 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MVIR-BSTOCK Price
| Open | 6.83 | Change | Price | % |
| High | 7.39 | 1 Day | -0.09 | -1.27 |
| Low | 6.83 | 1 Week | 0.05 | 0.72 |
| Close | 7.00 | 1 Month | -0.65 | -8.50 |
| Volume | 6245 | 1 Year | -1.58 | -18.41 |
| 52 Week High 10.02 | 52 Week Low 6.91 | ||||
ST Sweden Most Active Stocks
| FING-B | 0.03 | -25.00% |
| WYLD | 0.01 | 0.00% |
| SBB-B | 4.10 | 0.49% |
| TELIA | 30.18 | -0.26% |
| HDW-B | 0.00 | % |
| CYB1 | 0.01 | 0.00% |
| NIBE-B | 42.17 | 0.19% |
| LUNE | 21.97 | 6.65% |
| ERIC-B | 89.10 | -0.13% |
| ABLI | 0.42 | 0.00% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| MVIR-B Daily Charts |
MVIR-B Intraday Charts |
Whats New @ Bazaartrend |
MVIR-B Free Analysis |
|
|
MVIR-B Important Levels Intraday
| RESISTANCE | 8.08 |
| RESISTANCE | 7.73 |
| RESISTANCE | 7.52 |
| RESISTANCE | 7.31 |
| SUPPORT | 6.69 |
| SUPPORT | 6.48 |
| SUPPORT | 6.27 |
| SUPPORT | 5.92 |
MVIR-B Forecast December 2024
| 4th UP Forecast | 10.06 |
| 3rd UP Forecast | 9.08 |
| 2nd UP Forecast | 8.47 |
| 1st UP Forecast | 7.87 |
| 1st DOWN Forecast | 6.13 |
| 2nd DOWN Forecast | 5.53 |
| 3rd DOWN Forecast | 4.92 |
| 4th DOWN Forecast | 3.94 |
MVIR-B Weekly Forecast
| 4th UP Forecast | 8.43 |
| 3rd UP Forecast | 7.97 |
| 2nd UP Forecast | 7.69 |
| 1st UP Forecast | 7.40 |
| 1st DOWN Forecast | 6.60 |
| 2nd DOWN Forecast | 6.31 |
| 3rd DOWN Forecast | 6.03 |
| 4th DOWN Forecast | 5.57 |
MVIR-B Forecast2024
| 4th UP Forecast | 14.15 |
| 3rd UP Forecast | 11.86 |
| 2nd UP Forecast | 10.44 |
| 1st UP Forecast | 9.02 |
| 1st DOWN Forecast | 4.98 |
| 2nd DOWN Forecast | 3.56 |
| 3rd DOWN Forecast | 2.14 |
| 4th DOWN Forecast | -0.15 |
Medivir AB (publ) ( ST Sweden Symbol : MVIR-B )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MVIR-B Business Profile
Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology. The company markets Xerclear for use in the treatment of labial herpes under the Zoviduo name; and simeprevir. It develops Remetinostat, which has completed phase II clinical trial for treating cutaneous T-cell lymphoma, as well as in phase II clinical trial for treating basal cell carcinoma. The company also develops MIV-818, which is in phase Ia clinical trial for treating liver cancer; and MIV-711, which is in phase II clinical trial for treating osteoarthritis. It sells its products in Sweden, the Nordic region, Europe, the United States, and the rest of the world. The company has a research collaboration with the Drug Discovery and Development Platform at SciLifeLab for the discovery of antivirals for SARS CoV-2; and a licensing agreement with the Tango Therapeutics for a preclinical research program, as well as Ubiquigent Limited for the preclinical research program USP7. Medivir AB (publ) was founded in 1988 and is based in Huddinge, Sweden. Address: Lunastigen 7, Huddinge, Sweden, 141 22
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service